1. Home
  2. ELVN vs NTGR Comparison

ELVN vs NTGR Comparison

Compare ELVN & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • NTGR
  • Stock Information
  • Founded
  • ELVN 2016
  • NTGR 1996
  • Country
  • ELVN United States
  • NTGR United States
  • Employees
  • ELVN N/A
  • NTGR N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • NTGR Telecommunications Equipment
  • Sector
  • ELVN Health Care
  • NTGR Utilities
  • Exchange
  • ELVN Nasdaq
  • NTGR Nasdaq
  • Market Cap
  • ELVN 1.2B
  • NTGR 941.6M
  • IPO Year
  • ELVN 2020
  • NTGR N/A
  • Fundamental
  • Price
  • ELVN $20.52
  • NTGR $31.70
  • Analyst Decision
  • ELVN Strong Buy
  • NTGR Strong Buy
  • Analyst Count
  • ELVN 5
  • NTGR 3
  • Target Price
  • ELVN $41.20
  • NTGR $36.33
  • AVG Volume (30 Days)
  • ELVN 399.0K
  • NTGR 602.0K
  • Earning Date
  • ELVN 11-12-2025
  • NTGR 10-29-2025
  • Dividend Yield
  • ELVN N/A
  • NTGR N/A
  • EPS Growth
  • ELVN N/A
  • NTGR N/A
  • EPS
  • ELVN N/A
  • NTGR 2.16
  • Revenue
  • ELVN N/A
  • NTGR $697,865,000.00
  • Revenue This Year
  • ELVN N/A
  • NTGR $4.49
  • Revenue Next Year
  • ELVN $20.05
  • NTGR $3.83
  • P/E Ratio
  • ELVN N/A
  • NTGR $14.71
  • Revenue Growth
  • ELVN N/A
  • NTGR 0.41
  • 52 Week Low
  • ELVN $13.30
  • NTGR $18.75
  • 52 Week High
  • ELVN $29.79
  • NTGR $36.86
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.61
  • NTGR 49.60
  • Support Level
  • ELVN $21.08
  • NTGR $31.55
  • Resistance Level
  • ELVN $22.36
  • NTGR $36.86
  • Average True Range (ATR)
  • ELVN 1.00
  • NTGR 1.77
  • MACD
  • ELVN 0.04
  • NTGR -0.44
  • Stochastic Oscillator
  • ELVN 43.98
  • NTGR 8.59

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

Share on Social Networks: